Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed cannabis producer, has announced it will report its third quarter fiscal 2024 earnings results on Tuesday, August 13, 2024, before the market opens. The company will host a conference call to discuss the results at 8:00 am Eastern Time on the same day. Interested parties can register for the call using the provided link. A webcast of the call will also be available, with a replay accessible for 90 days following the event on Organigram's investor relations website.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), un importante produttore di cannabis autorizzato, ha annunciato che reporterà i suoi risultati finanziari del terzo trimestre dell'esercizio 2024 il martedì 13 agosto 2024, prima dell'apertura del mercato. L'azienda terrà una conference call per discutere i risultati alle 8:00 AM ora orientale dello stesso giorno. Le parti interessate possono registrarsi per la chiamata utilizzando il link fornito. Sarà disponibile anche una trasmissione in diretta della chiamata, con una registrazione accessibile per 90 giorni dopo l'evento sul sito delle relazioni con gli investitori di Organigram.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), un destacado productor de cannabis con licencia, ha anunciado que reportará sus resultados financieros del tercer trimestre del año fiscal 2024 el martes 13 de agosto de 2024, antes de la apertura del mercado. La empresa realizará una llamada conferencia para discutir los resultados a las 8:00 AM hora del Este ese mismo día. Las partes interesadas pueden registrarse para la llamada utilizando el enlace proporcionado. También estará disponible una transmisión web de la llamada, con una repetición accesible durante 90 días después del evento en el sitio web de relaciones con inversores de Organigram.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), 선도적인 면허를 가진 대마초 생산업체가 2024 회계년도 제3분기 실적 발표를 2024년 8월 13일 화요일, 시장 개장 전에 발표한다고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오전 8시에 실적에 대해 논의하기 위해 컨퍼런스 콜을 개최할 예정입니다. 관심 있는 분들은 제공된 링크를 통해 전화 회의에 등록할 수 있습니다. 또한, 전화 회의의 웹캐스트가 제공되며, 이벤트 이후 90일 동안 Organigram의 투자자 관계 웹사이트에서 다시 볼 수 있습니다.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), un producteur de cannabis licencié de premier plan, a annoncé qu'il publiera ses résultats financiers du troisième trimestre de l'exercice 2024 le mardi 13 août 2024, avant l'ouverture du marché. L'entreprise tiendra une conférence téléphonique pour discuter des résultats à 8h00 heure de l'Est le même jour. Les parties intéressées peuvent s'inscrire à l'appel en utilisant le lien fourni. Une diffusion en direct de l'appel sera également disponible, avec un replay accessible pendant 90 jours après l'événement sur le site Web des relations avec les investisseurs d'Organigram.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ein führender lizenzierter Cannabis-Produzent, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2024 am Dienstag, 13. August 2024, vor der Markteröffnung melden wird. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Interessierte Parteien können sich über den bereitgestellten Link für die Konferenz anmelden. Eine Webübertragung der Konferenz wird ebenfalls verfügbar sein, mit einer Aufzeichnung, die 90 Tage nach der Veranstaltung auf der Investor Relations-Website von Organigram zugänglich ist.
- None.
- None.
The Company will host a conference call to discuss its results with details as follows:
Date: Tuesday, August 13, 2024
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://registrations.events/direct/Q4I9676663358
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/291354315
Participants will receive their details via email.
A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose primary wholly owned subsidiary, Organigram Inc. is a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806828266/en/
For Media enquiries:
Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
For Investor Relations enquiries:
Max Schwartz, Director of Investor Relations
investors@organigram.ca
Source: Organigram Holdings Inc.
FAQ
When will Organigram (OGI) report its Q3 2024 earnings?
What time is Organigram's (OGI) Q3 2024 earnings call scheduled for?
How can investors access Organigram's (OGI) Q3 2024 earnings call?
How long will the replay of Organigram's (OGI) Q3 2024 earnings call be available?
